Indian Telmisartan Exporters: Complete Supplier Ranking with Market Share — 413 Manufacturers (2026) — TransData Nexus

Q: Who is the largest telmisartan supplier from India?

CIPLA LIMITED is the largest telmisartan exporter from India with a 98.4% market share and export value of $10.8B.

Q: How many telmisartan suppliers are there in India?

There are 413 active telmisartan exporters in India, collectively shipping $11.0B worth of telmisartan across 11,086 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top telmisartan suppliers from India?

The top 5 telmisartan suppliers from India — CIPLA LIMITED, MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED, ARISTO PHARMACEUTICALS PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED — together control 99.3% of total telmisartan export value from India.

Suresh Sormare

Telmisartan

India Pharmaceutical Trade Intelligence

$11.0B413 Suppliers132 CountriesHS 30049079

ExportsIndia → GERMANY98.4%India → HUNGARY0.5%

ImportsGERMANY → India$1.9B MALTA → India$18.5M

#1 Supplier: CIPLA LIMITED #1 Buyer: B LOGISTIK

Telmisartan Suppliers from India (2026) — 413 Exporters, $11.0B Market | TransData Nexus | TransData Nexus

Who Exports Telmisartan from India — 413 Suppliers Behind a $11.0B Market

India's telmisartan export market is supplied by 413 active exporters who collectively shipped $11.0B across 11,086 shipments. CIPLA LIMITED leads with a 98.4% market share, followed by MYLAN LABORATORIES LIMITED and INTAS PHARMACEUTICALS LIMITED. The top 5 suppliers together control 99.3% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published May 2026

India's Top Telmisartan Suppliers & Exporters — 413 manufacturers, $11.0B export market, top destinations and formulations — Telmisartan supplier data — 413 exporters · $11.0B market · 11,086 shipmentsTransData Nexus · Indian Customs Data

Top Telmisartan Exporters from India — Ranked by Export Value

CIPLA LIMITED is the leading telmisartan exporter from India, holding a 98.4% share of the $11.0B market across 11,086 shipments from 413 exporters. The top 5 suppliers — CIPLA LIMITED, MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED, ARISTO PHARMACEUTICALS PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED — collectively control 99.3% of total export value, indicating a highly concentrated market. Individual shares are: CIPLA LIMITED (98.4%), MYLAN LABORATORIES LIMITED (0.6%), INTAS PHARMACEUTICALS LIMITED (0.1%), ARISTO PHARMACEUTICALS PRIVATE LIMITED (0.1%), ALEMBIC PHARMACEUTICALS LIMITED (0.1%).

Top Telmisartan Exporters from India

Ranked by export value · 413 active suppliers · Indian Customs (DGFT) data

May 2026

Top Telmisartan Exporters from India — Ranked by Export Value. 413 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Telmisartan — Export Intelligence Video

Visual overview of India's telmisartan supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's telmisartan pharmaceutical supplier landscape — $11.0B in total trade, 413 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Telmisartan exporters

Certification and compliance status for top Telmisartan suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
CIPLA LIMITED	Approved	Yes	Yes	Multiple	Cipla has received approvals from the FDA, WHO-GMP, and EU GMP, indicating compl
MYLAN LABORATORIES LIMITED	Approved	Yes	Yes	Multiple	Mylan Laboratories holds FDA, WHO-GMP, and EU GMP certifications, reflecting adh
INTAS PHARMACEUTICALS LIMITED	Approved	Yes	Yes	Multiple	Intas Pharmaceuticals has obtained FDA, WHO-GMP, and EU GMP approvals, ensuring
ALEMBIC PHARMACEUTICALS LIMITED	Approved	Yes	Yes	Multiple	Alembic Pharmaceuticals has received FDA, WHO-GMP, and EU GMP certifications, in
GLENMARK PHARMACEUTICALS LIMITED	Warning Letter (July 2025	Yes	Yes	Multiple	Glenmark Pharmaceuticals received an FDA warning letter in July 2025 for its Mad
MICRO LABS LIMITED	Approved	Yes	Yes	Multiple	Micro Labs Limited holds FDA, WHO-GMP, and EU GMP certifications, reflecting adh
MSN LABORATORIES PRIVATE LIMITED	Approved	Yes	Yes	Multiple	MSN Laboratories has obtained FDA, WHO-GMP, and EU GMP approvals, ensuring compl
TORRENT PHARMACEUTICALS LTD	Approved	Yes	Yes	Multiple	Torrent Pharmaceuticals holds FDA, WHO-GMP, and EU GMP certifications, indicatin
MARKSANS PHARMA LIMITED	Approved	Yes	Yes	Multiple	Marksans Pharma has received FDA, WHO-GMP, and EU GMP certifications, reflecting

TransData Nexus reviewed the regulatory standing of 9 leading Telmisartan exporters from India. 8 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Telmisartan sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as "India's pharmaceutical capital," has a rich history in bulk drug manufacturing. The establishment of Indian Drugs and Pharmaceuticals Limited (IDPL) in 1961 marked the city's foray into the pharmaceutical sector. Over the decades, Hyderabad has attracted numerous national and global companies, solidifying its position as a hub for active pharmaceutical ingredients (APIs) production. As of 2010, the city manufactured one-third of India's bulk drugs and 16% of biotechnology products, contributing to its reputation as "India's pharmaceutical capital" and the "Genome Valley of India."

The city's infrastructure supports large-scale API manufacturing, making it a pivotal player in the supply chain for drugs like Telmisartan. Companies such as Natco Pharma, headquartered in Hyderabad, exemplify the region's capacity in producing both APIs and finished dosage formulations.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its prowess in pharmaceutical formulations. Gujarat's pharmaceutical industry ranks number one in India, with a 33% share in drug manufacturing and a 28% share in drug exports. The state boasts 130 USFDA-certified drug manufacturing facilities, with Ahmedabad and Vadodara being central to this success.

Vadodara, in particular, is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907. Alembic Pharmaceuticals produces formulations for therapeutic areas such as cardiology, dermatology, diabetes, ophthalmology, and infectious diseases for domestic and international markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Telmisartan exporters from India

April 2024

Acquisition

Cipla Limited — Cipla acquires Ivia Beaute's personal care business for ₹130 crore

In April 2024, Cipla Limited acquired the distribution and marketing business of Ivia Beaute Pvt Ltd for ₹130 crore, with an additional ₹110 crore contingent on milestones. This acquisition aims to expand Cipla's consumer health portfolio by incorporating Ivia's personal care brands. IMPACT: This acquisition is not directly related to Telmisartan exports and is unlikely to impact Cipla's position in the Telmisartan market.

Impact: This acquisition is not directly related to Telmisartan exports and is unlikely to impact Cipla's position in the Telmisartan market.

2025

Acquisition

Alembic Pharmaceuticals Limited — Alembic Pharmaceuticals acquires Utility Therapeutics for $12 million

In 2025, Alembic Pharmaceuticals' U.S. subsidiary acquired Utility Therapeutics Ltd for $12 million, adding the FDA-approved urinary tract infection drug Pivya (pivmecillinam 185 mg) to its portfolio. IMPACT: This acquisition does not pertain to Telmisartan and is unlikely to affect Alembic's Telmisartan export activities.

Impact: This acquisition does not pertain to Telmisartan and is unlikely to affect Alembic's Telmisartan export activities.

Common Questions — Telmisartan Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which telmisartan supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, CIPLA LIMITED leads with 1,619 recorded shipments worth $10.8B. MYLAN LABORATORIES LIMITED (240 shipments) and INTAS PHARMACEUTICALS LIMITED (461 shipments) are also established high-volume exporters.

Q How many telmisartan manufacturers are there in India?

India has 413 active telmisartan exporters with a combined export market of $11.0B across 11,086 shipments to 132 countries. The top 5 suppliers hold 99.3% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for telmisartan from India?

Average FOB unit price: $5.49 per unit, ranging from $0.00 to $5219.14. Average shipment value: $990.0K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Telmisartan

Telmisartan

Who Exports Telmisartan from India — 413 Suppliers Behind a $11.0B Market

Top Telmisartan Exporters from India — Ranked by Export Value

Top Telmisartan Exporters from India

Related Analysis

Need Details?

Telmisartan — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Recent M&A, Collaborations & Capacity Expansions

Cipla Limited — Cipla acquires Ivia Beaute's personal care business for ₹130 crore

Alembic Pharmaceuticals Limited — Alembic Pharmaceuticals acquires Utility Therapeutics for $12 million

Common Questions — Telmisartan Suppliers from India

Q Which telmisartan supplier from India is the most reliable for bulk orders?

Q How many telmisartan manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for telmisartan from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Mumbai-Thane-Raigad — Export Gateway

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Intas Pharmaceuticals Limited — Intas acquires Actavis UK and Ireland for £603 million

Analysis Methodology